5.1. Deficiency of CREBH Exacerbates Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH). Here, CREB3L3 is linked to metabolic dysfunction-associated steatohepatitis.